Company registration number 05304904 (England and Wales)
CELENTYX LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
CELENTYX LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 10
CELENTYX LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
as restated
Notes
£
£
£
£
Fixed assets
Tangible assets
4
79,049
83,706
Current assets
Debtors
5
609,116
410,697
Cash at bank and in hand
574,746
743,981
1,183,862
1,154,678
Creditors: amounts falling due within one year
6
(262,659)
(428,173)
Net current assets
921,203
726,505
Total assets less current liabilities
1,000,252
810,211
Creditors: amounts falling due after more than one year
7
(3,749)
(26,241)
Provisions for liabilities
(19,762)
(15,904)
Net assets
976,741
768,066
Capital and reserves
Called up share capital
8
100
100
Share premium account
230,842
230,842
Capital redemption reserve
23
23
Other reserves
13,598
11,250
Profit and loss reserves
732,178
525,851
Total equity
976,741
768,066
CELENTYX LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024
31 December 2024
- 2 -
For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 26 September 2025 and are signed on its behalf by:
Professor N M Barnes
Director
Company registration number 05304904 (England and Wales)
CELENTYX LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
Share capital
Share premium account
Capital redemption reserve
Other reserves
Profit and loss reserves
Total
£
£
£
£
£
£
As restated for the period ended 31 December 2023:
Balance at 1 January 2023
100
230,842
23
8,902
325,913
565,780
Prior year adjustment
-
-
(2)
(2)
As restated
100
230,842
23
8,902
325,911
565,778
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
-
-
-
199,940
199,940
Share based payments
11
-
-
-
2,348
2,348
Balance at 31 December 2023
100
230,842
23
11,250
525,851
768,066
Year ended 31 December 2024:
Profit and total comprehensive income for the year
-
-
-
-
206,327
206,327
Share based payments
11
-
-
-
2,348
2,348
Balance at 31 December 2024
100
230,842
23
13,598
732,178
976,741
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
1
Accounting policies
Company information
Celentyx Limited is a private company limited by shares incorporated in England and Wales. The registered office is Birmingham Research Park, Edgbaston, Birmingham, B15 2SQ.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Prior period adjustment
During the accounts preparation process, it was identified that the issue of the M shares & U shares which occurred in the financial year ended 31 December 2022 had not been recorded. This adjustment has resulted in profits available for distribution at 31 December 2024 decreasing by £2.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
25% reducing balance
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.6
Cash at bank and in hand
Cash at bank and in hand are basic financial assets and include cash in bank only.
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include trade debtors, other debtors, and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including trade creditors, corporation tax, other taxation and social security, and other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 6 -
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.12
Share-based payments
Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black-Scholes model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.
1.13
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
1.14
Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Total
13
12
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2024
175,286
Additions
18,161
At 31 December 2024
193,447
Depreciation and impairment
At 1 January 2024
91,580
Depreciation charged in the year
22,818
At 31 December 2024
114,398
Carrying amount
At 31 December 2024
79,049
At 31 December 2023
83,706
The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.
2024
2023
£
£
Plant and equipment
36,527
48,703
36,527
48,703
The depreciation charge in respect of such assets amounted to £12,176 (2023: £16,234)
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
535,460
240,060
Other debtors
73,656
170,637
609,116
410,697
6
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
63,886
115,436
Corporation tax
64,001
50,417
Other taxation and social security
16,208
26,089
Other creditors
118,564
236,231
262,659
428,173
Included within other creditors falling due within one year are obligations under hire purchase of £22,492 (2023: £22,492), which are secured on the assets to which they relate.
7
Creditors: amounts falling due after more than one year
2024
2023
£
£
Other creditors
3,749
26,241
Included within other creditors falling due within one year are obligations under hire purchase of £3,749 (2023: £26,241), which are secured on the assets to which they relate.
8
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 1p each
9,790
9,790
98
98
U shares of £1 each
1
1
1
1
M shares of £1 each
1
1
1
1
9,792
9,792
100
100
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
9
Operating lease commitments
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2024
2023
£
£
13,636
46,362
10
Share-based payment transactions
Number of share options
Weighted average exercise price
2024
2023
2024
2023
Number
Number
£
£
Outstanding at 1 January 2024 and 31 December 2024
1,096
1,096
35.91
35.91
Exercisable at 31 December 2024
The options outstanding at 31 December 2024 had an exercise price of £35.91, and a remaining contractual life of 5.21 years.
Inputs were as follows:
2024
2023
Weighted average share price
35.91
35.91
Weighted average exercise price
35.91
35.91
Expected volatility
50.00
50.00
Expected life
10.00
10.00
Risk free rate
1.21
1.21
During the year, the company recognised a charge of £2,348 (2023: £2,348) which related to equity settled share based payment transactions.
CELENTYX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 10 -
11
Prior period adjustment
Reconciliation of changes in equity
1 January
31 December
2023
2023
£
£
Adjustments to prior year
Issue of M shares
1
1
Issue of U shares
1
1
Deemed as paid up
(2)
(2)
Total adjustments
-
-
Equity as previously reported
565,778
768,066
Equity as adjusted
565,778
768,066
Analysis of the effect upon equity
Share capital
2
2
Profit and loss reserves
(2)
(2)
-
-
Reconciliation of changes in profit for the previous financial period
2023
£
Total adjustments
-
Profit as previously reported
199,940
Profit as adjusted
199,940
Notes to reconciliation
During the accounts preparation process, it was identified that the issue of the M shares & U shares which occurred in the financial year ended 31 December 2022 had not been recorded. This adjustment has resulted in profits available for distribution at 31 December 2024 decreasing by £2.
2024-12-312024-01-01falsefalsefalse26 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityProfessor A K BoydProfessor J GordonProfessor N M Barnes2025-09-26053049042024-01-012024-12-31053049042024-12-31053049042023-12-3105304904core:OtherPropertyPlantEquipment2024-12-3105304904core:OtherPropertyPlantEquipment2023-12-3105304904core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3105304904core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3105304904core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3105304904core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3105304904core:CurrentFinancialInstruments2024-12-3105304904core:CurrentFinancialInstruments2023-12-3105304904core:ShareCapital2024-12-3105304904core:ShareCapital2023-12-3105304904core:SharePremium2024-12-3105304904core:SharePremium2023-12-3105304904core:CapitalRedemptionReserve2024-12-3105304904core:CapitalRedemptionReserve2023-12-3105304904core:OtherMiscellaneousReserve2024-12-3105304904core:OtherMiscellaneousReserve2023-12-3105304904core:RetainedEarningsAccumulatedLosses2024-12-3105304904core:RetainedEarningsAccumulatedLosses2023-12-3105304904core:SharePremiumcore:PriorPeriodIncreaseDecrease2022-12-3105304904core:CapitalRedemptionReservecore:PriorPeriodIncreaseDecrease2022-12-3105304904core:RetainedEarningsAccumulatedLossescore:PriorPeriodIncreaseDecrease2022-12-3105304904core:ShareCapital2022-12-3105304904core:SharePremium2022-12-3105304904core:CapitalRedemptionReserve2022-12-3105304904core:OtherMiscellaneousReserve2022-12-3105304904core:RetainedEarningsAccumulatedLosses2022-12-31053049042022-12-3105304904core:ShareCapitalOrdinaryShareClass12024-12-3105304904core:ShareCapitalOrdinaryShareClass12023-12-3105304904core:ShareCapitalOrdinaryShareClass32024-12-3105304904core:ShareCapitalOrdinaryShareClass32023-12-3105304904core:ShareCapitalOrdinaryShareClass42024-12-3105304904core:ShareCapitalOrdinaryShareClass42023-12-3105304904core:ShareCapitalOrdinaryShares2024-12-3105304904core:ShareCapitalOrdinaryShares2023-12-3105304904bus:Director32024-01-012024-12-3105304904core:RetainedEarningsAccumulatedLosses2023-01-012023-12-31053049042023-01-012023-12-3105304904core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3105304904core:PlantMachinery2024-01-012024-12-3105304904core:OtherPropertyPlantEquipment2023-12-3105304904core:OtherPropertyPlantEquipment2024-01-012024-12-3105304904core:WithinOneYear2024-12-3105304904core:WithinOneYear2023-12-3105304904core:Non-currentFinancialInstruments2024-12-3105304904core:Non-currentFinancialInstruments2023-12-3105304904bus:OrdinaryShareClass12024-01-012024-12-3105304904bus:OrdinaryShareClass32024-01-012024-12-3105304904bus:OrdinaryShareClass42024-01-012024-12-3105304904bus:OrdinaryShareClass12024-12-3105304904bus:OrdinaryShareClass12023-12-3105304904bus:OrdinaryShareClass32024-12-3105304904bus:OrdinaryShareClass32023-12-3105304904bus:OrdinaryShareClass42024-12-3105304904bus:OrdinaryShareClass42023-12-3105304904bus:AllOrdinaryShares2024-12-3105304904bus:AllOrdinaryShares2023-12-31053049042023-12-3105304904bus:PrivateLimitedCompanyLtd2024-01-012024-12-3105304904bus:FRS1022024-01-012024-12-3105304904bus:AuditExemptWithAccountantsReport2024-01-012024-12-3105304904bus:Director12024-01-012024-12-3105304904bus:Director22024-01-012024-12-3105304904bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3105304904bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP